肝硬化脾切除术利弊权衡细思量

doi:10.3969/j.issn.1672-5069.2019.04.002

Abstract

Huang Zhiyin, Li Jing. Splenectomy in patients with liver cirrhosis：the pros and cons[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 459-461.

[1] Al-raimi K,Zheng SS. Postoperative outcomes after open splenectomy versus laparoscopic splenectomy in cirrhotic patients:a meta-analysis. Hepatobiliary Pancreat Dis Int,2016,15:14-20.
[2] Wang YB,Zhang JY,Zhang F,et al.Partial splenic artery embolization to treat hypersplenism secondary to hepatic cirrhosis:A Meta-analysis. Am Surg,2017,83:274-283.
[3] Bolognesi M,Merkel C,Sacerdoti D,et al.Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis,2002,34:144-150.
[4] McCormick PA,Murphy KM. Splenomegaly,hypersplenism and coagulation abnormalities in liver disease. Baillieres Best Pract Res Clin Gastroenterol,2000,14:1009-1031.
[5] Bolognesi M,Sacerdoti D,Bombonato G,et al.Change in portal flow after liver transplantation:effect on hepatic arterial resistance indices and role of spleen size. Hepatology,2002,35:601-608.
[6] Romano A,Hou X,Sertorio M,et al.FOXP3+ regulatory T cells in hepatic fibrosis and splenomegaly caused by Schistosoma japonicum:The spleen may be a major source of Tregs in subjects with splenomegaly. PLoS Negl Trop Dis,2016,10:e0004306.
[7] Chu H,Han W,Wang L,et al.Long-term efficacy of subtotal splenectomy due to portal hypertension in cirrhotic patients. BMC Surg,2015,15:89.
[8] Basili S,Raparelli V,Napoleone L,et al.Platelet count does not predict bleeding in cirrhotic patients:Results from the PRO-LIVER Study. Am J Gastroenterol,2018,113:368-375.
[9] Traub A,Giebink GS,Smith C,et al.Splenic reticuloendothelial function after splenectomy,spleen repair,and spleen autotransplantation. N Engl J Med,1987,317:1559-1564.
[10] Lisman T,Violi F.Cirrhosis as a risk factor for venous thrombosis. Thromb Haemost,2017,117:3-5.
[11] Francoz C,Valla D,Durand F.Portal vein thrombosis, cirrhosis,and liver transplantation. J Hepatol,2012,57:203-212.
[12] King H,Shumacker HB,Jr. Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg,1952,136:239-242.
[13] de'Angelis N,Abdalla S,Lizzi V,et al. Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy. Surgery,2017,162:1219-1230.
[14] Kawanaka H,Akahoshi T,Kinjo N,et al.Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg,2010,251:76-83.
[15] Krauth MT,Lechner K,Neugebauer EA,et al.The postoperative splenic/portal vein thrombosis after splenectomy and its prevention-an unresolved issue. Haematologica,2008,93:1227-1232.
[16] Ushitora Y,Tashiro H,Takahashi S,et al.Splenectomy in chronic hepatic disorders:portal vein thrombosis and improvement of liver function. Dig Surg,2011,28:9-14.
[17] Endo K,Oikawa T,Kakisaka K,et al.The impact of portal vein thrombosis on the prognosis and liver function of nonmalignant cirrhotic patients. Scand J Gastroenterol,2018,53:1340-1346.
[18] Trautwein C,Friedman SL,Schuppan D,et al.Hepatic fibrosis:Concept to treatment. J Hepatol,2015,62:S15-24.
[19] Yip LY,Aw CC,Lee SH,et al.The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat. Hepatology,2018,67:282-295.
[20] Asanoma M,Ikemoto T,Mori H,et al.Cytokine expression in spleen affects progression of liver cirrhosis through liver-spleen cross-talk. Hepatol Res,2014,44:1217-1223.
[21] Aoyama T,Kuwahara-Arai K,Uchiyama A,et al.Spleen-derived lipocalin-2 in the portal vein regulates Kupffer cells activation and attenuates the development of liver fibrosis in mice. Lab Invest,2017,97:890-902.
[22] Bronte V,Pittet MJ.The spleen in local and systemic regulation of immunity. Immunity,2013,39:806-818.
[23] Davies JM,Lewis MP,Wimperis J,et al.Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen:prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force. Br J Haematol,2011,155:308-317.
[24] Hosea SW,Brown EJ,Hamburger MI,et al.Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med,1981,304:245-250.
[25] Sarangi J,Coleby M,Trivella M,et al.Prevention of post splenectomy sepsis:a population based approach. J Public Health Med,1997,19:208-212.
[26] Lombardo S,Espejo JJ,Perez-Montilla ME,et al.The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation. Radiologia,2018,60:94-104.

Splenectomy in patients with liver cirrhosis：the pros and cons

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764.
[2]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[3]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[4]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[5]	Zhu Yage, Liu Jinfeng.. Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels [J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
[6]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[7]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[8]	Liu Li, Yang Lie, Chen Haiyang, et al.. Changes of hemodynamics after splenectomy combined with pericardial devascularization in patients with cirrhotic portal hypertention complicated by splenic artery steal syndrome [J]. Journal of Practical Hepatology, 2019, 22(6): 884-887.
[9]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[10]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[11]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[12]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[13]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[14]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[15]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.